|
At Getz Pharma, our new product development program generally includes pre-formulation studies, excipient compatibility studies, analytical
methods development and validation, formulation development and optimization, formal stability studies, and manufacturing process development according to ICH Guidelines. At Getz Pharma we also have a quality program dedicated to continuous improvement of product quality
of running products at a dedicated high-tech R&D site.
These laboratory-scale batches are subjected to stability as per the ICH guidelines. The complete documentation of the laboratory data is presented in a format compliant with European standards or in an FDA-compliant mode, depending on the targeted markets.
Getz Pharma also has research capabilities specializing in the design, testing
and evaluation of healthcare products for life sciences companies
worldwide. Our technology development team consists of scientists drawn
from some of the best research organizations. Through a combination of
state-of-the art analytical instrumentation, infrastructure meeting global
development standards, and world-class expertise and level of scientific
excellence, we ensure that our clients receive true added value to their
R&D projects, completed in the speediest and most cost effective manner
without compromising data quality.
At Getz Pharma, we understand that a sound infrastructure meeting global standards is an essential part of achieving our deliverables. Our laboratories are well equipped to handle:
- Tablets, immediate release
- Tablets, controlled or sustained release including MUPs
- Tablets, enteric coated
- Capsules, hard gelatin or HPMC, filled with powder, granules, mini tablets or pellets
- Capsules, controlled or sustained release
- Oral liquids and suspensions
- Ocular drops, nasal sprays and inhalations
- Semi-solid dosage forms
- Injectable dosage forms including lyophilized products
- An ICH-compliant stability management program for testing stability
|
